Free Trial

Champlain Investment Partners LLC Lowers Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Axon Enterprise logo with Aerospace background

Champlain Investment Partners LLC reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 74.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 172,985 shares of the biotechnology company's stock after selling 509,435 shares during the period. Champlain Investment Partners LLC owned approximately 0.23% of Axon Enterprise worth $102,808,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. New Wave Wealth Advisors LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth about $40,000. Y.D. More Investments Ltd purchased a new stake in Axon Enterprise in the fourth quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise during the fourth quarter valued at approximately $53,000. GPS Wealth Strategies Group LLC raised its stake in shares of Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after acquiring an additional 40 shares in the last quarter. Finally, Versant Capital Management Inc lifted its holdings in shares of Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after acquiring an additional 95 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $626.45.

Read Our Latest Analysis on Axon Enterprise

Axon Enterprise Stock Up 3.2 %

Axon Enterprise stock traded up $17.58 during trading hours on Tuesday, hitting $559.51. 125,129 shares of the stock traded hands, compared to its average volume of 783,355. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The firm's 50-day moving average price is $553.80 and its two-hundred day moving average price is $568.36. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market cap of $42.87 billion, a PE ratio of 144.58, a PEG ratio of 5.17 and a beta of 1.13.

Insider Activity

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines